When: Q3 2026 beat-and-raise with HashiCorp contribution disclosure, no goodwill impairment, AND confirmed daily close above $258 on volume ≥10M

Then: Upgrade rating to Overweight

When: Sustained close below $215 on volume >30M, OR AI disclosure vacuum deepens without Q3 clarification, OR Q3 earnings miss with guidance reset

Then: Downgrade to Underweight

TRIM TO 3-5% UNDERWEIGHT WITH $258 STOP; REJECT FULL LIQUIDATION

• Trader proposes trim to 3-5% underweight (SELL), NOT full exit — preserves dividend income ($6.30/share annual payout, 2.78% yield) and FCF yield (~5%)
• Technical setup is bullish: MACD fresh bullish crossover with expanding histogram, RSI at 57 (bullish but not overbought), price sustained above 50 SMA, higher lows sequence intact since July
• Fundamentals are sound: 28 consecutive years of dividend growth, FCF over $12B, Net debt/EBITDA 3.3x, ROE 34.5%, Q2 2026 EPS $2.27
• Q2 2026 net income rebounded to $2.17B from depressed Q1, suggesting acquisition is already generating revenue; no goodwill impairment visible in operating metrics
• Valuation not stretched: P/E 22.1 trailing / 18.9 forward, 17% expected EPS growth; PEG of 2.30 reflects trailing 2024 dip from Kyndryl spinoff charges
• Goodwill of $74.6B (49% of assets) is manageable given Red Hat ($34B, 2019) was successfully integrated; current acquisition appears revenue-generating
• Full exit destroys dividend income and AI/quantum optionality, and crystallizes timing risk right after bullish MACD crossover
• Aggressive Analyst's Accenture comparison is flawed — IBM's revenue mix (Red Hat, watsonx, hybrid cloud) differs from pure-play consulting
• Core conservative case: trim reduces exposure to macro headwinds and integration drag while preserving defensive floor (dividend, low beta, FCF yield, optionality)
• Risk management principle: if wrong and IBM reaches $280, underperformance is a few percentage points; if wrong and holding full size into $200 drop, underperformance is 20%

→ vs aggressive: Selling at $243 into a fresh MACD bullish crossover with RSI at 57 and price above 50 SMA risks locking in losses if this is the start of a sustained recovery toward $258 rather than a trap

→ vs aggressive: The yield trap argument misunderstands risk-adjusted investing — $6.30/share dividend is covered by $12B FCF with 5% FCF yield and 28 years of consecutive increases, not a distressed or doomed payout

→ vs aggressive: Accenture analogy doesn't map — IBM's Red Hat, watsonx AI, and hybrid cloud mix differs from pure-play consulting demand profile; 7.6% revenue growth and 240bps margin expansion indicate transformation is working

→ vs aggressive: Goodwill impairment bear case is theoretical — Q2 2026 net income of $2.17B rebounded from Q1, indicating successful acquisition integration and no visible impairment in operating metrics

→ vs aggressive: Forward estimates not about to be cut — IBM just reported clean Q2 with $2.27 EPS; Aggressive Analyst is importing peer pressure from ACN's warning

→ vs aggressive: Full exit destroys the dividend ($6.30/share) and AI/quantum optionality while crystallizing timing risk — this is impatience masquerading as conviction, not intelligent risk management

SELL with phased execution; maintain 3-5% underweight with dynamic sizing favoring higher end of band on pullback to $227-230 support; re-engage above $258 on sustained closes above 200-day SMA

• Q2 2026 EPS: $2.27
• 2025 revenue growth accelerated to 7.6%, strongest pace in years
• Operating margins expanded 240 basis points
• Free cash flow exceeds $12 billion, covers dividend nearly 2x
• ROE of 34.5% is exceptional
• Dividend yield of 2.78% with 28-year Aristocrat streak; payout ratio vs FCF is healthy
• Trailing P/E of 22x with PEG of 2.30; forward P/E of 18.9x
• Forward EPS growth expectation of 17% embedded in current multiple
• Stock sits 5.7% below falling 200-day SMA at $258
• Short-term momentum bullish with MACD bullish crossover but extended above upper Bollinger band
• Upper Bollinger band: extended; Middle Bollinger band: $234; Lower Bollinger band: $227-230
• $227-230 zone represents support at lower Bollinger band and recent swing lows
• NASA lunar AI partnership moved stock 2% (interpreted as constructive signal, not exhaustion)
• Market cap approximately $235 billion
• 5% yields with zero Fed cut probability through December 2026 creates hostile macro backdrop for duration-sensitive equities
• PEG of 2.30 is backward-looking; normalized PEG compresses meaningfully when excluding depressed 2024 net income from Kyndryl spinoff charges
• Scaled execution over 3-5 trading sessions preferred to single print at $243; targeting average exit $237-243
• Re-engagement threshold: $258 with sustained closes and expanding volume above 200-day SMA
• Stop level consistent at $258 to force re-engagement only on structural confirmation

→ vs aggressive: Full-liquidation escalation is overreach; stock generates exceptional cash (FCF >$12B, ROE 34.5%) and should not be liquidated at current metrics despite technical headwinds

→ vs aggressive: Dividend yield of 2.78% is not a yield trap given healthy payout ratio vs FCF and 28-year Aristocrat streak; exiting to 4% money market changes risk profile without improving quality

→ vs aggressive: NASA partnership 2% reaction interpretation is too simplistic; $235B market cap stock digesting open-source AI news without selling is constructive, indicating underlying bid still exists

→ vs aggressive: PEG of 2.30 is backward-looking including Kyndryl spinoff charges; normalized PEG compresses meaningfully; 18.9x forward P/E with 17% EPS growth is at least plausible given 2025 acceleration

→ vs conservative: Trim is correct but treating it as end state misses opportunity for slightly more active posture; scaling execution over sessions captures mean reversion and improves average fill price

→ vs conservative: Macro framing is correct but incomplete; while IBM's mature cash flow is less punished than high-multiple growth, the multiple is still exposed to hostile rate regime and cannot expand without Fed accommodation